A strategy for large-scale phosphoproteomics and SRM-based validation of human breast cancer tissue samples.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of Proteome Research

• Publication date

  2012-10-17

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1021/pr3005474PMID 22985185
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The hallmarks of cancer

  2012cited by this paper
• Strategy for SRM-based verification of biomarker candidates discovered by iTRAQ method in limited breast cancer tissue samples.

  2012cited by this paper
• Keratin 8 phosphorylation regulates keratin reorganization and migration of epithelial tumor cells

  2012cited by this paper
• Phosphoproteomic differences in major depressive disorder postmortem brains indicate effects on synaptic function

  2012cited by this paper
• Characterization of Human Myotubes From Type 2 Diabetic and Nondiabetic Subjects Using Complementary Quantitative Mass Spectrometric Methods*

  2011cited by this paper
• A pipeline that integrates the discovery and verification of plasma protein biomarkers reveals candidate markers for cardiovascular disease

  2011cited by this paper
• Novel Molecular Markers of Malignancy in Histologically Normal and Benign Breast

  2011cited by this paper
• Universal and confident phosphorylation site localization using phosphoRS.

  2011cited by this paper
• LMO7 Mediates Cell-Specific Activation of the Rho-Myocardin-Related Transcription Factor-Serum Response Factor Pathway and Plays an Important Role in Breast Cancer Cell Migration

  2011cited by this paper
• CK8/18 expression, the basal phenotype, and family history in identifying BRCA1‐associated breast cancer in the Ontario site of the Breast Cancer Family Registry

  2011cited by this paper
• Differential recruitment of nuclear receptor coregulators in ligand-dependent transcriptional repression by estrogen receptor-α

  2011cited by this paper
• A targeted proteomics–based pipeline for verification of biomarkers in plasma

  2011cited by this paper
• Measurement of protein phosphorylation stoichiometry by selected reaction monitoring mass spectrometry.

  2010cited by this paper
• Aberrations of ERBB2 and TOP2A genes in breast cancer

  2010cited by this paper
• BRCA1 and BRCA2: breast/ovarian cancer susceptibility gene products and participants in DNA double-strand break repair.

  2010cited by this paper
• Proteome, phosphoproteome, and N-glycoproteome are quantitatively preserved in formalin-fixed paraffin-embedded tissue and analyzable by high-resolution mass spectrometry.

  2010cited by this paper
• Quantification of Cardiovascular Biomarkers in Patient Plasma by Targeted Mass Spectrometry and Stable Isotope Dilution*

  2009cited by this paper
• Large‐scale proteomic analysis of tyrosine‐phosphorylation induced by T‐cell receptor or B‐cell receptor activation reveals new signaling pathways

  2009cited by this paper
• A New Approach for Quantitative Phosphoproteomic Dissection of Signaling Pathways Applied to T Cell Receptor Activation*

  2009cited by this paper
• The phosphoproteomics data explosion.

  2009cited by this paper
• Stoichiometric Quantification of Akt Phosphorylation Using LC-MS/MS

  2009cited by this paper
• Nuclear receptor coregulator SNP discovery and impact on breast cancer risk

  2009cited by this paper
• Epidermal Growth Factor Receptor Phosphorylation Sites Ser991 and Tyr998 Are Implicated in the Regulation of Receptor Endocytosis and Phosphorylations at Ser1039 and Thr1041*

  2009cited by this paper
• Targeted Quantitative Analysis of Streptococcus pyogenes Virulence Factors by Multiple Reaction Monitoring*S

  2008cited by this paper
• A quantitative atlas of mitotic phosphorylation

  2008cited by this paper
• Solid tumor proteome and phosphoproteome analysis by high resolution mass spectrometry.

  2008cited by this paper
• Determination of the specific activity of CDK1 and CDK2 as a novel prognostic indicator for early breast cancer.

  2008cited by this paper
• SCC-112 gene is involved in tumor progression and promotes the cell proliferation in G2/M phase

  2008cited by this paper
• Quantitative Analysis of Synaptic Phosphorylation and Protein Expression*S

  2008cited by this paper
• Phase transfer surfactant-aided trypsin digestion for membrane proteome analysis.

  2008cited by this paper
• Proteomics Analysis of Protein Kinases by Target Class-selective Prefractionation and Tandem Mass Spectrometry *S

  2007cited by this paper
• Quantitative, Multiplexed Assays for Low Abundance Proteins in Plasma by Targeted Mass Spectrometry and Stable Isotope Dilution*S

  2007cited by this paper
• ATM and ATR Substrate Analysis Reveals Extensive Protein Networks Responsive to DNA Damage

  2007cited by this paper
• Mitochondrial Phosphoproteome Revealed by an Improved IMAC Method and MS/MS/MS*S

  2007cited by this paper
• Global proteomic profiling of phosphopeptides using electron transfer dissociation tandem mass spectrometry

  2007cited by this paper
• Large-scale phosphorylation analysis of alpha-factor-arrested Saccharomyces cerevisiae.

  2007cited by this paper
• Multiple reaction monitoring for robust quantitative proteomic analysis of cellular signaling networks

  2007cited by this paper
• Large-scale phosphorylation analysis of mouse liver

  2007cited by this paper
• Regulating insulin signaling and beta-cell function through IRS proteins.

  2006cited by this paper
• Quantitative Mass Spectrometric Multiple Reaction Monitoring Assays for Major Plasma Proteins*

  2006cited by this paper
• Phosphoproteomic analysis of rat liver by high capacity IMAC and LC-MS/MS.

  2006cited by this paper
• Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.

  2006cited by this paper
• MUC1 oncoprotein stabilizes and activates estrogen receptor alpha.

  2006cited by this paper
• Regulating insulin signaling and β-cell function through IRS proteinsThis paper is one of a selection of papers published in this Special Issue, entitled Second Messengers and Phosphoproteins—12th International Conference.

  2006cited by this paper
• MUC1 Oncoprotein Stabilizes and Activates Estrogen Receptor α

  2006cited by this paper
• Comprehensive Identification of Phosphorylation Sites in Postsynaptic Density Preparations*S

  2006cited by this paper
• New approaches to the treatment of inflammatory disorders small molecule inhibitors of p38 MAP kinase.

  2006cited by this paper
• The Roles of Multiple Proteomic Platforms in a Pipeline for New Diagnostics

  2005cited by this paper
• Proteomic Analysis of in Vivo Phosphorylated Synaptic Proteins*

  2005cited by this paper
• Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer

  2005cited by this paper
• MAPK signalling pathways as molecular targets for anti-inflammatory therapy--from molecular mechanisms to therapeutic benefits.

  2005cited by this paper
• Immunoaffinity profiling of tyrosine phosphorylation in cancer cells

  2005cited by this paper
• Highly Selective Enrichment of Phosphorylated Peptides from Peptide Mixtures Using Titanium Dioxide Microcolumns*

  2005cited by this paper
• Specificity of immobilized metal affinity-based IMAC/C18 tip enrichment of phosphopeptides for protein phosphorylation analysis.

  2005cited by this paper
• Phosphoproteomic Analysis of the Developing Mouse Brain*S

  2004cited by this paper
• Large-scale characterization of HeLa cell nuclear phosphoproteins.

  2004cited by this paper
• Multiplexed Protein Quantitation in Saccharomyces cerevisiae Using Amine-reactive Isobaric Tagging Reagents*S

  2004cited by this paper
• Quantification of C‐reactive protein in the serum of patients with rheumatoid arthritis using multiple reaction monitoring mass spectrometry and 13C‐labeled peptide standards

  2004cited by this paper
• Gene expression profiling predicts clinical outcome of breast cancer

  2002cited by this paper
• Phosphoproteome analysis by mass spectrometry and its application to Saccharomyces cerevisiae

  2002cited by this paper
• Stable Isotope Labeling by Amino Acids in Cell Culture, SILAC, as a Simple and Accurate Approach to Expression Proteomics*

  2002cited by this paper
• Characterization of topoisomerase II alpha gene amplification and deletion in breast cancer.

  1999cited by this paper
• Characterization of topoisomerase IIα gene amplification and deletion in breast cancer

  1999cited by this paper
• Evidence for phosphorylation of serine 753 in CFTR using a novel metal‐ion affinity resin and matrix‐assisted laser desorption mass spectrometry

  1997cited by this paper
• BRCA1 mutations in primary breast and ovarian carcinomas.

  1994cited by this paper
• Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer

  1994cited by this paper

• Clinical Applications of Phosphoproteomics: Illuminating Cancer Signaling and Enabling Rational Therapeutic Strategies.

  2026cites this paper
• Serum fucosylated receptor expression-enhancing protein 5 as a biomarker for early stage pancreatic cancer

  2025cites this paper
• Phosphoproteomic profiling of feline mammary carcinoma: Insights into tumor grading and potential therapeutic targets

  2025cites this paper
• Spindle apparatus coiled‐coil protein 1 (SPDL1) serves as a novel prognostic biomarker in triple‐negative breast cancer

  2024cites this paper
• Label-Free Multiple Reaction Monitoring-Mass Spectrometry for Quantifying Phosphopeptides from Extracellular Vesicles.

  2024cites this paper
• Chemoproteomics reveals immunogenic and tumor-associated cell surface substrates of ectokinase CK2α.

  2024cites this paper
• Targeted Quantification of Protein Phosphorylation and Its Contributions towards Mathematical Modeling of Signaling Pathways

  2023cites this paper
• Omics-Based Investigations of Breast Cancer

  2023cites this paper
• Critical Analysis of Multi-Omic Data from a Strain of Plutella xylostella Resistant to Bacillus thuringiensis Cry1Ac Toxin.

  2022cites this paper
• Identification of CD14 and lipopolysaccharide-binding protein as novel biomarkers for sarcoidosis using proteomics of serum extracellular vesicles

  2022cites this paper
• ICOSL expressed in triple-negative breast cancer can induce Foxp3+ Treg cell differentiation and reverse p38 pathway activation.

  2022cites this paper
• Improving Phosphoproteomics Profiling Using Data-Independent Mass Spectrometry.

  2022cites this paper
• iTRAQ-based proteome profiling revealed the role of Phytochrome A in regulating primary metabolism in tomato seedling

  2021cites this paper
• Proteomics of serum extracellular vesicles identifies a novel COPD biomarker, fibulin-3 from elastic fibres

  2021cites this paper
• CD14 and LBP as Novel Biomarkers for Sarcoidosis by Proteomics of Extracellular Vesicles

  2021cites this paper
• Production mechanism of semicarbazide from protein in Chinese softshell turtles at different drying temperatures based on TMT-tagged quantitative proteomics

  2021cites this paper
• Integrating site-specific peptide reporters and targeted mass spectrometry enables rapid substrate-specific kinase assay at the nanogram cell level.

  2021cites this paper
• SRM-MS for Posttranslational Modification Analysis

  2020cites this paper
• Comprehensive characterization of the phosphoproteome of gastric cancer from endoscopic biopsy specimens

  2020cites this paper
• Effect of Tricaprin on Cardiac Proteome in a Mouse Model for Triacylglyceride Deposit Cardiomyovasculopathy.

  2020cites this paper
• Quantitative proteomic analysis of human corneal epithelial cells infected with HSV-1.

  2019cites this paper
• Strategies based on sum of peak intensities may better reflect protein expression than peak area integration in iTRAQ protein expression measurement by LC-MS/MS using a TripleTOF 5600+ platform

  2019cites this paper
• Synthetic phosphopeptides: From spike-in standards to affinity tools for protein-protein interaction studies.

  2019cites this paper
• Proteomics for cancer drug design

  2019influential citation
• Utilization of Proteomic Technologies for Precision Oncology Applications.

  2019cites this paper
• Sum of peak intensities outperforms peak area integration in iTRAQ protein expression measurement by LC-MS/MS using a TripleTOF 5600+ platform

  2019cites this paper
• Galectin-7 as a potential biomarker of Stevens-Johnson syndrome/toxic epidermal necrolysis: identification by targeted proteomics using causative drug-exposed peripheral blood cells.

  2019cites this paper
• Elevated carbon dioxide levels lead to proteome-wide alterations for optimal growth of a fast-growing cyanobacterium, Synechococcus elongatus PCC 11801

  2019cites this paper
• Post-translational quantitation by SRM/MRM: applications in cardiology

  2018cites this paper
• Characterizing disease-associated changes in post-translational modifications by mass spectrometry

  2018cites this paper
• Personalization of prostate cancer therapy through phosphoproteomics

  2018cites this paper
• Phosphoproteomics of Retinoblastoma: A Pilot Study Identifies Aberrant Kinases

  2018cites this paper
• The tyrosine kinase v-Src causes mitotic slippage by phosphorylating an inhibitory tyrosine residue of Cdk1

  2018cites this paper
• Growth Cone Phosphoproteomics Reveals that GAP-43 Phosphorylated by JNK Is a Marker of Axon Growth and Regeneration

  2018cites this paper
• Determination of Site-Specific Phosphorylation Ratios in Proteins with Targeted Mass Spectrometry.

  2018cites this paper
• Differential Phosphoproteomic Analysis of Recombinant Chinese Hamster Ovary Cells Following Temperature Shift.

  2017cites this paper
• Quantitative proteomics of breast tumors: Tissue quality assessment to clinical biomarkers

  2017cites this paper
• Deciphering the Acute Cellular Phosphoproteome Response to Irradiation with X-rays, Protons and Carbon Ions*

  2017cites this paper
• A Timely Shift from Shotgun to Targeted Proteomics and How It Can Be Groundbreaking for Cancer Research

  2017cites this paper
• Phosphoproteome of crab-eating macaque cerebral cortex characterized through multidimensional reversed-phase liquid chromatography/mass spectrometry with tandem anion/cation exchange columns.

  2017cites this paper
• Targeted mass spectrometry: An emerging powerful approach to unblock the bottleneck in phosphoproteomics.

  2017cites this paper
• [Analysis of contribution of protein phosphorylation in the development of the diseases].

  2017cites this paper
• Super-SILAC mix coupled with SIM/AIMS assays for targeted verification of phosphopeptides discovered in a large-scale phosphoproteome analysis of hepatocellular carcinoma.

  2017cites this paper
• Analysis of the role of protein phosphorylation in the development of diseases

  2017cites this paper
• Quantitation of putative colorectal cancer biomarker candidates in serum extracellular vesicles by targeted proteomics

  2017cites this paper
• Real-time iTRAQ-based proteome profiling revealed the central metabolism involved in nitrogen starvation induced lipid accumulation in microalgae

  2017cites this paper
• FAM83H and casein kinase I regulate the organization of the keratin cytoskeleton and formation of desmosomes

  2016cites this paper
• The clinical impact of recent advances in LC-MS for cancer biomarker discovery and verification

  2016cites this paper
• Casein kinase 1 is recruited to nuclear speckles by FAM83H and SON

  2016cites this paper
• Mass Spectrometric-Based Selected Reaction Monitoring of Protein Phosphorylation during Symbiotic Signaling in the Model Legume, Medicago truncatula

  2016cites this paper
• The use of elemental mass spectrometry in phosphoproteomic applications.

  2016cites this paper
• Quantitative proteomics and phosphoproteomics on serial tumor biopsies from a sorafenib-treated HCC patient

  2016cites this paper
• iTRAQ-Based Quantitative Proteomic Comparison of Early- and Late-Passage Human Dermal Papilla Cell Secretome in Relation to Inducing Hair Follicle Regeneration

  2016cites this paper
• Proteomics insights into DNA damage response and translating this knowledge to clinical strategies

  2016cites this paper
• Separation Techniques in Proteomics and Possibilities as Drug Targets of Protein Post Translational Modifications

  2016cites this paper
• Quantitative Analysis of Tissue Samples by Combining iTRAQ Isobaric Labeling with Selected/Multiple Reaction Monitoring (SRM/MRM).

  2016cites this paper
• Targeted Phosphoproteome Analysis Using Selected/Multiple Reaction Monitoring (SRM/MRM).

  2016cites this paper
• Application of Computational Proteomics and Lipidomics in Drug Discovery

  2016cites this paper
• Improved Proteome and Phosphoproteome Analysis on a Cation Exchanger by a Combined Acid and Salt Gradient.

  2016cites this paper
• Targeted phosphoproteomics of insulin signaling using data-independent acquisition mass spectrometry

  2015cites this paper
• Differential Proteome Analysis Identifies TGF-β-Related Pro-Metastatic Proteins in a 4T1 Murine Breast Cancer Model

  2015cites this paper
• Rapid Phosphoproteomic Effects of Abscisic Acid (ABA) on Wild-Type and ABA Receptor-Deficient A. thaliana Mutants*

  2015cites this paper
• Phosphoproteomics in the Age of Rapid and Deep Proteome Profiling

  2015cites this paper
• Quantitation of protein post-translational modifications using isobaric tandem mass tags.

  2015cites this paper
• Immobilized Metal Affinity Chromatography Coupled to Multiple Reaction Monitoring Enables Reproducible Quantification of Phospho-signaling*

  2015cites this paper
• A Combined Shotgun and Targeted Mass Spectrometry Strategy for Breast Cancer Biomarker Discovery.

  2015cites this paper
• Recent findings and technological advances in phosphoproteomics for cells and tissues

  2015influential citation
• Current strategies and findings in clinically relevant post-translational modification-specific proteomics

  2015cites this paper
• Important options available — from start to finish — for translating proteomics results to clinical chemistry

  2015cites this paper
• Application of molecular technologies for phosphoproteomic analysis of clinical samples

  2014cites this paper
• Computational proteomics: designing a comprehensive analytical strategy.

  2014cites this paper
• Mass spectrometric analysis of the phosphorylation levels of the SWI/SNF chromatin remodeling/tumor suppressor proteins ARID1A and Brg1 in ovarian clear cell adenocarcinoma cell lines.

  2014cites this paper
• Discovery of Colorectal Cancer Biomarker Candidates by Membrane Proteomic Analysis and Subsequent Verification using Selected Reaction Monitoring (SRM) and Tissue Microarray (TMA) Analysis*

  2014cites this paper
• The selected reaction monitoring/multiple reaction monitoring-based mass spectrometry approach for the accurate quantitation of proteins: clinical applications in the cardiovascular diseases

  2014cites this paper
• Analytical challenges translating mass spectrometry‐based phosphoproteomics from discovery to clinical applications

  2014cites this paper
• Collaborative contributions of basic scientists and clinicians to disease biomarker discovery

  2014cites this paper
• Developing a Proteomic Prognostic Signature for Breast Cancer Patients

  2014cites this paper
• Proteomic analysis of tissue samples in translational breast cancer research

  2014cites this paper
• Tissue Proteomics for the Next Decade? Towards a Molecular Dimension in Histology

  2014cites this paper
• Phosphoprotein Secretome of Tumor Cells as a Source of Candidates for Breast Cancer Biomarkers in Plasma

  2014cites this paper
• The Neddylation-Cullin 2-RBX1 E3 Ligase Axis Targets Tumor Suppressor RhoB for Degradation in Liver Cancer*

  2014influential citation
• Mass spectrometry‐driven phosphoproteomics: patterning the systems biology mosaic

  2014cites this paper
• Lamin B2 prevents chromosome instability by ensuring proper mitotic chromosome segregation

  2014cites this paper
• Proteomic analysis of phosphorylation in cancer

  2014cites this paper
• Application of Computational Proteomics and Lipidomics in Drug

  2014cites this paper
• A novel mechanism of keratin cytoskeleton organization through casein kinase I&agr; and FAM83H in colorectal cancer

  2013influential citation
• In-depth membrane proteomic study of breast cancer tissues for the generation of a chromosome-based protein list.

  2013cites this paper
• Is phosphoproteomics ready for clinical research?

  2013cites this paper
• Enrichment specificity of micro and nano-sized titanium and zirconium dioxides particles in phosphopeptide mapping.

  2013cites this paper
• Quantitative proteomic analysis of microdissected breast cancer tissues: comparison of label-free and SILAC-based quantification with shotgun, directed, and targeted MS approaches.

  2013cites this paper
• Quantitative phosphoproteomic profiling of human non-small cell lung cancer tumors.

  2013cites this paper
• Establishment of TSH β real-time monitoring system in mammalian photoperiodism

  2013cites this paper